Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-06

Clinical Trial Update: Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and potential efficacy of azithromycin to achieve remission in children with steroid-sensitive nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: University of Child Health Sciences and Children's Hospital, Lahore | Conditions: Nephrotic Syndrome | Phase 1 | Status: COMPLETED